Bioskin GmbH   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Hamburg Germany (1992)

Organization Overview

First Clinical Trial
2007
NCT00418730
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Bioskin GmbH | bioskin, Hamburg | bioskin Institute for Dermatological Research and Development GmbH

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Alopecia (Phase 2)

Alopecia Areata (Phase 2)

Psoriasis (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 12
  • # of Trial APIs: 13